NCT04628364View on ClinicalTrials.gov

The Natural History of Metachromatic Leukodystrophy Study (HOME Study)

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

January 31, 2024

Study Completion Date

March 30, 2025

Conditions
Metachromatic Leukodystrophy
Trial Locations (1)

06810

National Organization for Rare Disorders, Danbury

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

National Organization for Rare Disorders

OTHER

NCT04628364 - The Natural History of Metachromatic Leukodystrophy Study (HOME Study) | Biotech Hunter | Biotech Hunter